Overview

Botswana TDF/FTC Oral HIV Prophylaxis Trial

Status:
Completed

Trial end date:
2011-03-01

Target enrollment:

Participant gender:

Summary

This study tested whether taking a pill of tenofovir and emtricitabine (two antiretroviral medicines) was safe for sexually-active young adults in Botswana without HIV infection and whether it reduced their risk of getting an HIV infection.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Centers for Disease Control and Prevention

Collaborators:

Botswana Ministry of Health
Gilead Sciences

Treatments:

Emtricitabine
Tenofovir